Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

DEJA VU U Understand..Coming to a Cosco Near You..ahoooooooooooo


Q: What can you say about the pending acquisition of Provista?

Douglas MacLellan, CEO, Radient Pharmaceuticals: That’s obviously out there. One, we have a business relationship with Provista that looks very promising whether we buy them or not. So we have advanced the better part of the economic equation with cooperative agreements- with them- to develop the lung cancer test kit and they expect to be marketing that widely, at places like Costco and other retailers by the second quarter. That can be an enormously profitable business for us.

We have, right now, a cooperative agreement in place to do that without ever acquiring them. At the end of the day, would it be more interesting to have them as one of our subsidiaries? Yeah, we’ve thought so but we haven’t been in a financial position to complete that transaction. We may be in a financial position to do that in 2011. We need to determine whether we need a shareholder meeting, relative values, etc. But remember, even if we never do that we’ve got a great business relationship that can be enormously profitable.

http://www.biomedreports.com/2011012762916/radients-ceo-believes-company-should-qualify-to-continue-trading-on-the-amex.html


http://rustinintustin.com/radient-pharmaceuticals-announces-collaboration-agreement-with-provista-life-marketwatch-press-release-7/